Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop Type 2 diabetes

  1. Mi Lai
  2. Dana Al Rijjal
  3. Hannes L Röst  Is a corresponding author
  4. Feihan F Dai  Is a corresponding author
  5. Erica P Gunderson  Is a corresponding author
  6. Michael B Wheeler  Is a corresponding author
  1. University of Toronto, Canada
  2. Kaiser Permanente Northern California, United States

Abstract

Approximately 35% of women with Gestational Diabetes (GDM) progress to Type2 Diabetes (T2D) within 10 years. However, links between GDM and T2D are not well understood. We used a well-characterised GDM prospective cohort of 1,035 women following up to 8 years postpartum. Lipidomics profiling covering >1000 lipids, was performed on fasting plasma samples from participants 6-9week postpartum (171 incident T2D vs. 179 controls). We discovered 311 lipids positively and 70 lipids negatively associated with T2D risk. The upregulation of glycerolipid metabolism involving triacylglycerol and diacylglycerol biosynthesis suggested activated lipid storage before diabetes onset. In contrast, decreased sphingomyelines, hexosylceramide and lactosylceramide indicated impaired sphingolipid metabolism. Additionally, a lipid signature was identified to effectively predict future diabetes risk. These findings demonstrate an underlying dyslipidemia during the early postpartum in those GDM women who progress to T2D and suggest endogenous lipogenesis may be a driving force for future diabetes onset.

Data availability

Lipidomic data have been deposited in Harvard Dataverse: https://doi.org/10.7910/DVN/KUDDSF.Source data files have been provided for Figures 2, 3 , 4 and 6 as supporting files.

The following data sets were generated
    1. Michael Wheeler
    (2020) SWIFT lipidomics data
    Harvard Dataverse, 10.7910/DVN/KUDDSF.

Article and author information

Author details

  1. Mi Lai

    Department of Physiology, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  2. Dana Al Rijjal

    Department of Physiology, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  3. Hannes L Röst

    Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Canada
    For correspondence
    hannes.rost@utoronto.ca
    Competing interests
    No competing interests declared.
  4. Feihan F Dai

    Department of Physiology, University of Toronto, Toronto, Canada
    For correspondence
    f.dai@utoronto.ca
    Competing interests
    No competing interests declared.
  5. Erica P Gunderson

    Division of Research, Kaiser Permanente Northern California, Oakland, United States
    For correspondence
    Erica.Gunderson@kp.org
    Competing interests
    Erica P Gunderson, Erica P. Gunderson is affiliated with Kaiser Permanente. EPG has declared a research grant from Janssen Pharmaceuticals Company. EPG has no other financial interests to declare..
  6. Michael B Wheeler

    Physiology, University of Toronto, Toronto, Canada
    For correspondence
    michael.wheeler@utoronto.ca
    Competing interests
    Michael B Wheeler, MBW has declared a research grant from Janssen Pharmaceuticals Company.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7480-7267

Funding

Canadian Institutes of Health Research (FRN 143219)

  • Michael B Wheeler

Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD050625)

  • Erica P Gunderson

The National Institute of Digestive, Diabetes and Kidney Disease (R01 DK118409)

  • Erica P Gunderson

Janssen Pharmaceuticals (430086739)

  • Erica P Gunderson
  • Michael B Wheeler

Banting and Best Diabetes Centre, University of Toronto (postdoctoral fellowships)

  • Mi Lai

Ontario Graduate Scholarship (Graduate Student Fellowship)

  • Dana Al Rijjal

Banting and Best Diabetes Centre, University of Toronto (Graduate Student Fellowship)

  • Dana Al Rijjal

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study design and all procedures were approved by the Kaiser Permanente Northern California Institutional Review Board (protocol numbers #CN-04EGund-03-H and #1279812-10) and Office of Research Ethics at University of Toronto (protocol number #38188). All participants gave written informed consent before taking part in the research exams.

Copyright

© 2020, Lai et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,324
    views
  • 224
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mi Lai
  2. Dana Al Rijjal
  3. Hannes L Röst
  4. Feihan F Dai
  5. Erica P Gunderson
  6. Michael B Wheeler
(2020)
Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop Type 2 diabetes
eLife 9:e59153.
https://doi.org/10.7554/eLife.59153

Share this article

https://doi.org/10.7554/eLife.59153

Further reading

    1. Medicine
    Tumininu S Faniyan, Xinyi Zhang ... Kavaljit H Chhabra
    Short Report

    The kidneys facilitate energy conservation through reabsorption of nutrients including glucose. Almost all the filtered blood glucose is reabsorbed by the kidneys. Loss of glucose in urine (glycosuria) is offset by an increase in endogenous glucose production to maintain normal energy supply in the body. How the body senses this glucose loss and consequently enhances glucose production is unclear. Using renal Slc2a2 (also known as Glut2) knockout mice, we demonstrate that elevated glycosuria activates the hypothalamic-pituitary-adrenal axis, which in turn drives endogenous glucose production. This phenotype was attenuated by selective afferent renal denervation, indicating the involvement of the afferent nerves in promoting the compensatory increase in glucose production. In addition, through plasma proteomics analyses we observed that acute phase proteins - which are usually involved in the body’s defense mechanisms against a threat – were the top candidates which were either upregulated or downregulated in renal Slc2a2 KO mice. Overall, afferent renal nerves contribute to promoting endogenous glucose production in response to elevated glycosuria and loss of glucose in urine is sensed as a biological threat in mice. These findings may be useful in improving the efficiency of drugs like SGLT2 inhibitors that are intended to treat hyperglycemia by enhancing glycosuria but are met with a compensatory increase in endogenous glucose production.

    1. Developmental Biology
    2. Medicine
    Stephen E Flaherty III, Olivier Bezy ... Zhidan Wu
    Research Article

    From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a ‘thrifty phenotype’ is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.